Healthcare Sector Analysis & Updated Stock Recommendations (2025)

By Editorial Team -
The healthcare sector continues to thrive in 2025, fuelled by key innovations in biotechnology, genomics, AI-driven healthcare solutions, and medical devices. Below are updated stock recommendations, reflecting the most promising opportunities for growth in the sector.


1. GeneDx (WGS) – Leading the Charge in Genomics

Sector: Biotechnology / Genomics
Stock Growth: +1,108% (1-Year Performance)
Market Cap: $2.93B USD
Key Driver: Growth in precision medicine and genetic research. GeneDx continues to dominate the genomics and personalized medicine industry by delivering cutting-edge genetic-based therapies. As demand for customized healthcare solutions rises, GeneDx is emerging as a top biotech stock for 2025.

Top Institutional Holders:

  • BlackRock Inc.
  • Vanguard Group Inc.
  • Summit Partners Public Asset Management LLC
  • William Blair Investment Management, LLC
  • Lord, Abbett & Co. LLC
  • Fred Alger Management, LLC
  • Goldman Sachs Group Inc.
  • Oracle Investment Management Inc.
  • Casdin Capital, LLC
  • Corvex Management LP

2. Monopar Therapeutics (MNPR) – Targeted Cancer Treatments

  • Growth: +981%

  • Market Cap: $176M

  • Why It’s a Buy: Specializing in oncology research, Monopar is advancing targeted therapies for aggressive cancers and shows promising results in clinical trials, making it a top biotech pick in 2025. Its innovative approach to oncology has made it a standout biotech stock in early 2025.

3. Palantir Technologies (PLTR) – AI-Powered Healthcare Analytics

  • Growth: +260% (1-Year Performance)

  • Market Cap: $48.2B USD

  • Why It’s a Buy: Palantir’s AI-driven data analytics are transforming biotech research, hospital management, and drug discovery. Its extensive role in data-based decision-making within the healthcare sector positions it as a strong investment.

Top Institutional Holders:
  • Vanguard Group Inc.
  • BlackRock Inc.
  • ARK Investment Management LLC
  • Morgan Stanley
  • State Street Corporation

4. Intuitive Surgical (ISRG) – Robotics in Healthcare

  • Growth: +420%

  • Market Cap: $138B

  • Why It’s a Buy: Intuitive Surgical is a leader in robotic-assisted surgery, revolutionizing minimally invasive procedures. As hospitals continue to adopt advanced surgical robots, the company’s market share is poised to grow.

5. Illumina Inc. (ILMN) – Genomic Sequencing Powerhouse

  • Growth: +335%

  • Market Cap: $51B

  • Why It’s a Buy: Illumina’s next-generation sequencing platforms are a key enabler of personalized medicine, genetic testing, and cancer research. As genomics becomes increasingly critical to healthcare, Illumina is expected to see continued growth.

6. Teladoc Health Inc. (TDOC) – Leading Virtual Healthcare

  • Growth: +250%

  • Market Cap: $24B

  • Why It’s a Buy: As the telemedicine leader, Teladoc is expanding its AI-powered health consultations, mental health services, and specialty care. With growing demand for virtual care, Teladoc remains a top investment in 2025.


7. Apple Inc. (AAPL) – Healthcare through Wearables

  • Growth: +105%

  • Market Cap: $2.5T

  • Why It’s a Buy: While primarily a tech company, Apple is making strides in healthcare through wearable technology like the Apple Watch. With new features like ECG monitoring, blood oxygen sensors, and partnerships with healthcare providers, Apple is positioning itself at the intersection of tech and healthcare.

Investor Takeaways

  • Genomics & Precision Medicine: GeneDx, Illumina

  • AI in Healthcare: Palantir, Teladoc Health, Apple

  • Cancer Treatments & Immunotherapies: Monopar

  • Robotics & Medical Devices: Intuitive Surgical

These top healthcare stocks represent high-growth opportunities in 2025, focusing on genomics, AI-driven healthcare analytics, robotics, and personalized medicine. Investors looking for exposure to transformative trends in the healthcare sector should consider these stocks for their portfolios.

Comments

Post a Comment

Pages

Popular posts from this blog

Did Steve Jobs Refuse Treatment for Pancreatic Cancer?

By Editorial Team -
Image
On October 5, 2011, Steve Jobs died after a battle with a rare pancreatic cancer at age 56. But he may have lived longer if he sought proper medical care in time. When Apple co-founder Steve Jobs was first diagnosed with pancreatic cancer in 2003, his doctors advised him to seek surgery as soon as possible. Instead, he delayed the procedure for nine months and attempted to treat himself with alternative medicine. This fateful decision may have quickened Steve Jobs’ death — when he still could’ve been saved. Steve Jobs died from pancreatic cancer complications on October 5, 2011, just eight years after his initial diagnosis. He was only 56 years old when he died, but his cancer had taken such a toll on his body that he looked gaunt, frail, and much older than his actual age. It was a far cry from the robust, energetic man who had once pioneered the personal computer era.    ...
Read more

7 Best Crypto Exchanges Malaysia 2025

By Editorial Team -
Image
The best cryptocurrency exchanges work similarly to the best stock trading apps, offering competitive fees and resources on digital marketplaces like mobile or desktop. Crypto enthusiasts can easily buy, sell, and store popular digital currencies like Bitcoin or altcoins like Ethereum. Note that if you don't want to use your exchange's built-in wallet (if applicable), you'll need to set up an external crypto wallet, to store your assets securely. Here are some cryptocurrency exchanges you can use to buy Bitcoin or Crypto in Malaysia. 1. Luno (Previously known as BitX) Luno is the most popular digital asset exchange to buy Bitcoin or cryptocurrency in Malaysia which has served over 3 million users from more than 40 countries. They allow Malaysian users to buy Bitcoin, Ethereum, XRP and Bitcoin Cash through a Malaysian Ringgit (MYR) trading pair (i.e BTC/MYR). While they are probably the most renowned cryptocurrency exchange in Malaysia, the headquarter is located in South Af...
Read more

Glutathione vs NAD: What's the Difference?

By Editorial Team -
Image
What's the difference between glutathione and NAD? We will cover the essentials and explain about each of these nutrients below.  What is Glutathione? Glutathione or GSH (tripeptide of glutamic acid, cysteine, and glycine) is referred to as the body’s “master antioxidant” or the “mother of all antioxidants” because it is your body’s primary and most prevalent protector, found in all mammalian tissue. Types of Glutathione There is a lot of confusion about GSH and what makes an effective glutathione supplement. There are different types, different formulas, and a lot of different companies saying different things. L-Glutathione or Reduced Glutathione because it is the most commonly found, least expensive, and the true core behind other forms you will find. There is some debate whether L-Glutathione alone can be effective taken orally. The theory being the enzymes in your stomach break it down before it can ever reach the blood stream and become useful. Some  evidence ...
Read more

6 Best Cloud Kitchens in Kuala Lumpur and Selangor 2024

By Editorial Team -
Image
If you are looking for the best cloud kitchens in Malaysia, you've come to the right place. Like seemingly everything else, technology has been taking over the food industry. Traditionally, around  60% of new restaurants fail  within the first year, and almost 80% shut down before their fifth anniversary.  What are cloud kitchens (a.k.a. ghost kitchens, shared kitchens, dark kitchens or virtual kitchens)? They have been  in the news  a lot lately. So chances are that you have at least heard of them. On the surface, cloud kitchens are delivery-only restaurants.  Historically in tech, we have used the word "cloud" to mean either that the web-based processing happens at some remote data center or the files are saved at a data center. However, the meaning of the word has evolved lately to include anything that happens remotely so you can get the final product wherever you are. Cloud kitchens are restaurants that only have kitchens. They are essentially food pro...
Read more

Top Stocks and Crypto: April 2025 Update

By Editorial Team -
Image
As of April 6, 2025, the U.S. stock market continues to crash. Stocks are cratering after tariffs. Here's what's next for markets.  According to Business Insider : Investors have made their opinion clear: They hate the trade war . Stocks suffered their worst single-day loss in five years on Thursday. The S&P 500 dropped nearly 5%, the Dow lost 1,679 points, and the Nasdaq composite plunged 6%. Goldman Sachs said earlier this year that for every 5-percentage-point increase in the tariff rate, investors could expect S&P 500 earnings to fall by 1% to 2%. After Trump's Rose Garden address, the US tariff rate stood at about 20%. Goldman Sachs said earlier this year that for every 5-percentage-point increase in the tariff rate, investors could expect S&P 500 earnings to fall by 1% to 2%. After Trump's Rose Garden address, the US tariff rate stood at about 20%. "Protectionism feels good, but it's expensive," Michael Farr, the CEO and founder of the ...
Read more

Top 10 Pharma Companies by R&D Spend 2024

By Editorial Team -
Image
In 2024, the pharmaceutical industry witnessed significant shifts in research and development (R&D) investments, with companies like Merck & Co. and AstraZeneca making notable strategic decisions that impacted their positions among top R&D spenders. The average cost for major pharmaceutical companies to develop a drug in 2024 rose to $2.23 billion, up from $2.12 billion the previous year. This increase reflects the growing complexity and expense associated with bringing new therapies to market. ​( Fierce Biotech ) These developments illustrate the dynamic nature of R&D investments in the pharmaceutical sector, influenced by strategic partnerships, acquisitions, and the escalating costs of drug development. 1. Merck & Co. R&D SPENDING 2024: $17.9 billion Change from 2023: -41% Total 2024 revenue: $64.2 billion R&D budget as percentage of revenue: 28% Merck & Co.’s R&D spending plummeted from the deal-inflated high of 2023—and yet still came in $700 ...
Read more

The billionaire's social calendar for 2025: The must-attend events for the world's wealthiest business icons

By Editorial Team -
There are about 3,320 billionaires in the world. That's about 0.00004% of the global population. Despite their scarcity, billionaires are surprisingly easy to find. After all, birds of a feather — especially those of a small brood — flock their private jets together. At the start of the year, they descend en masse on Davos. In July, they fly to Sun Valley for the Allen & Company Conference. And they wrap it up with New Year's Eve in St. Barts. Here's where the wealthiest among us mingle, wheel and deal, and relax, and how you can join them — for a small price, of course. January: Davos After billionaires shake off their New Year's Eve hangovers, many join world leaders and head to Switzerland for the World Economic Forum's annual meeting in Davos to attend lavish dinners, hit the slopes, and discuss the global problem du jour, which, this year, is collaboration for the intelligent age." The event, which will take place from January 20 to 24, is invite-only ...
Read more

12 Best SME Business Loans in Malaysia 2025

By Editorial Team -
Image
SME or also known as Small and Medium-sized Enterprises are businesses that maintain revenues, assets, or a number of employees below a certain threshold. These business entities are often regarded as the heartbeat of Malaysia’s emerging and developing economies. Apart from providing vast numbers of employment opportunities, SME businesses are generally entrepreneurial in nature, helping to shape innovation. Generally, there are two criteria to be met in order for your business to qualify as an SME -- your annual sales turnover and the number of full time employees in your company. This also implies differently for each economy sector: Manufacturing (Small SMEs) Sales turnover RM300,000 to < RM15 million Full time employees 5 to < 75 people Manufacturing (Medium SMEs) Sales turnover RM15 million to < RM50 million Full time employees 75 to < 200 people Services & Others   (Small SMEs) Sales turnover RM300,000 to < RM3 million Full time employees 5 to < 30 ...
Read more

How to buy Bitcoin or Crypto in Malaysia 2025

By Editorial Team -
Image
Contents Introduction Types of Cryptocurrency Best Crypto Exchanges in Malaysia Bitcoin ATMs in Malaysia Peer-to-Peer Marketplace Step by Step Guide: Buy Bitcoin or cryptocurrency in Malaysia Is Cryptocurrency Legal in Malaysia? Is Crypto Taxable in Malaysia? Conclusion Frequently Asked Questions Introduction In December 2024,  Bitcoin set a new all-time high of USD 100,000  (RM442,000) for the first time. A cryptocurrency is a digital or virtual currency that is secured by cryptography, which makes it nearly impossible to counterfeit or double-spend.  Many cryptocurrencies are decentralised networks based on blockchain technology—a distributed ledger enforced by a disparate network of computers. A defining feature of cryptocurrencies is that central authorities generally do not issue them, rendering them theoretically immune to government interference or manipulation. Lately, many types of cryp...
Read more

FLCCC I-Care Early Treatment Protocol

By Editorial Team -
Image
The Front Line COVID-19 Critical Care (FLCCC) Alliance was initially formed as a working group under “emergency” conditions of the early COVID-19 pandemic in response to multiple early reports of COVID patients with an inexplicably high need for prolonged mechanical ventilation and an excessive mortality associated with the prevailing “supportive care only” recommendations disseminated by the majority of national and international health care organizations. Early treatment is critical and the most important factor in managing this disease. COVID-19 is a clinical diagnosis; a confirmed antigen or PCR test is not required. Treatment should be initiated immediately after the onset of flu-like symptoms. The multiple therapies and drugs in this protocol have different mechanisms of action and work synergistically during various phases of the disease. About this Protocol The information in this document is our recommended approach to COVID-19 based on the best (and most recent) literature. I...
Read more